Tag: Trials
“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans
Stempeucel-OA demonstrates durable 24-month efficacy & cartilage preservation in phase 3...
Peer-reviewed results published in Osteoarthritis and Cartilage Open show significant improvements in pain, function, and structural outcomes versus placebo
Datavant and Indegene partner to power more efficient clinical trial recruitment
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Roche partners 10 govt hospitals to strengthen clinical trial capabilities in...
Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 Trials
Sun Pharma’s phase 3 trials of ILUMYA support potential U.S. submission...
Both pivotal studies met their primary endpoint with statistically significant improvements based on ACR20 response rates at Week 24 with tildrakizumab 100 mg (ILUMYA) compared to placebo
Auriga Research signs strategic MoU with San Francisco Research Institute
The partnership outlines a joint framework to support clinical trials, regulatory pathways, digital health innovation, and international business development
Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction & a safety...
Lilly plans to submit efsitora for the treatment of adults with type 2 diabetes to global regulatory agencies by the end of this year
Parexel completes CDSCO registration
The registration under the new G.S.R 581(E) regulation reflects Parexel’s commitment to regulatory compliance and clinical research excellence in India
Philogen completes patient enrollment of Phase III FIBROSARC trial in soft...
All ongoing Fibromun trials are expected remain on track with their expected timelines
“There is a growing trend towards outsourcing clinical trials to India”
Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research Limited shares his vision for the company, latest developments, long-term growth, industry trends and future outlook